Oncoimmune
Organisation
Trials
Phase 3, Terminated, 2021, 11 people, 19 Sept 2019, clinicaltrials.gov
Phase 2, Completed, 2016, 44 people, 26 Jan 2016, clinicaltrials.gov
Organisation
Phase 3, Terminated, 2021, 11 people, 19 Sept 2019, clinicaltrials.gov
Phase 2, Completed, 2016, 44 people, 26 Jan 2016, clinicaltrials.gov